🇺🇸 FDA
Pipeline program

Recombinant human growth hormone

GenSci001-01

Approved small_molecule active

Quick answer

Recombinant human growth hormone for Achondroplasia is a Approved program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Indication
Achondroplasia
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials